Spironolactone use and the risk of breast and gynecologic cancers
Biggar, Bob, Anderson, Elisabeth, Wohlfahrt, Jan, & Melbye, Mads (2013) Spironolactone use and the risk of breast and gynecologic cancers. Cancer Epidemiology, 37(6), pp. 870-875.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||estrogen, furosemide, prescription drug, spironolactone, adult, aged, article, breast cancer, cancer diagnosis, cancer incidence, cancer risk, drug use, female, gynecologic cancer, human, major clinical study, priority journal, risk assessment, uterine c|
|Divisions:||Past > QUT Faculties & Divisions > Faculty of Built Environment and Engineering
Current > Institutes > Institute of Health and Biomedical Innovation
|Deposited On:||07 Oct 2014 07:00|
|Last Modified:||07 Oct 2014 07:05|
Repository Staff Only: item control page